• Lead two teams that provide analytics, forecasting, and primary research to deliver insights to a $12B+ business with market leading products Eliquis and Camzyos and pipeline products milvexian and MYK-224• Regularly interact with C-suite executives to provide performance and forecast updates and new analytical and market research insights that explain and help drive performance• Provide guidance and training to my two teams through one-on-one interactions, coaching, stretch assignments, and leadership opportunities• Collaborate with the broad Business Insights & Analytics (BI&A) organization to move towards an integrated analytical approach with more comprehensive and cohesive analytics and insights for commercialization• Assist BI&A leadership to drive internal initiatives that continuously improve and refine the organization’s purpose and elevate BI&A’s role within the organization• Align on key messages and analyses with US and WW Cardiovascular leadership for key meetings with both internal and external clients and investors including our quarterly earnings calls

• Led a team to deliver 3-year forecasts and explain performance to the US Commercial teams for Zeposia, Orencia, and the Oncology portfolio of products on an interim basis by analyzing secondary data, interpreting market research and incorporating key driver analyses• Drove analyses for strategic brand decisions with senior Immunology and Oncology commercial leadership, including the SVPs for Immunology and Oncology, VPs of the sales teams, and VPs of numerous brand teams• Collaborated with other matrix partners such as Finance, Access and Pricing, Patient Support Services, Supply Chain Demand Planning, Market Research, and other analytics teams• Assisted Investor Relations with the planning for quarterly earnings calls and other investor events by creating prep documents, anticipating analyst questions, and preparing C-suite executives

• Partnered with the Canada General Manager, Commercial Operations, and Finance to provide actionable insights, drive innovation, and deliver financial forecasts to regional leadership• Built and led a five-person team that delivers all forecasts, analytics, and market research for the Canadian market across all therapeutic areas including oncology, hematology, immunology, multiple sclerosis, and CV• Collaborated with other international market teams on research, performance updates, and event impacts• Encouraged career growth for team members through consistent feedback, regular development discussions, and appropriate stretch opportunities in areas of interest

• Worked in partnership with the US Commercial team in support of Melanoma, GU, and GI tumors by:o Delivering 3-year forecasts for financial activities such as Budget including assessing risks and opportunitieso Incorporating analytics and market research from BI&A partners into the evaluation of current performance o Collaborating with the US & WW Commercials team and other matrix partners to analyze and provide recommendations on strategic decisions including a new portfolio market access strategy, new launch scenario planning, performance tracking, as well as various business development opportunities• Prepared comprehensive enterprise-wide factbook for the CFO and CCO ahead of company earnings calls

• Key member of client demand planning team at large US-based pharmaceutical client for ex-US markets in Europe, Middle East, and Africa• Update forecast on monthly basis to provide latest view to supply chain team members• Worked as part of a client's forecasting team for multiple in-line products in the US• Developed patient- and Rx-based forecasting models• Created forecasts for new indications of in-line products• Worked with Marketing and Finance teams to develop complex end-of-life forecast for product facing new competition• Worked with client Finance and Marketing teams to answer ad-hoc analytics requests• Helped a client develop and streamline an online dashboard to house all financial information about inline and pipeline biotech products in multiple indications• Worked with a client's senior management to develop global strategies to deal with life cycle management, loss of exclusivity, and the onset of generic erosion across four different brands

• Valued the fund's private investments for eleven different private partnerships• Performed detailed cash flow analysis for the fund's real estate holdings• Analyzed financial statements of the fund's private equity holdings

• Created financial valuation models with Microsoft Excel including discounted cash flow analyses to help value early-stage biotech companies.• Created revenue and cost forecasting for early-stage biotech companies during the valuation process.• Screened for comparable companies by looking at drug development stages, significant event bias, and other criteria to help value early-stage biotech companies.• Performed a variety of analyses throughout the litigation process to support expert damages reports as well as commercial success reports in the pharmaceutical and biotech industries.• Helped write expert damages reports and commercial success reports• Analyzed financial statements for valuation or research purposes• Trained interns and new hires in Microsoft Excel• Worked with HR to manage the recruitment efforts in the New York office

• Assisted other Associates and senior-level colleagues on litigation cases involving financial valuation, financial modeling, and intellectual property matters.• Assisted a senior-level colleague research and write a professional article on the performance of CVRs in pharmaceutical acquisitions.